JD Health (06618.HK) released its interim performance report, with a profit attributable to shareholders of 3.437 billion yuan, an increase of 32.37% year-on-year.

Zhiying Finance APP reported that JD Health (06618.HK) released its interim results for the six months ending June 30, 2026. The group recorded revenue of RMB 40.888 billion, an increase of 15.9% year-on-year; operating profit under non-International Financial Reporting Standards was RMB 3.483 billion, a year-on-year increase of 40.3%; profit attributable to the owners of the company was RMB 3.437 billion, an increase of 32.37% year-on-year; basic earnings per share were RMB 1.08.